NeuroGyn AG has raised $4.8M in Series A funding. The Swiss medtech company develops neurotechnology for the international medical market, with a focus on surgical and stimulation systems for pelvic nerve disorders.
The company's stated mission is to help physicians improve the quality of life for patients with these conditions.
















